arrow
K

Krystien V.V. Lieve

bc children's hospital
H指数:22
被引数:1,448

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification

由ryanodine受体2介导的儿茶酚胺多形性室性心动过速:一项验证的风险分层

2025-12-010
PRE
An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia
2024-10-014
PRE
Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
2023-12-195
OAAI
An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia
2022-02-0132
OA
Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia
2021-11-0115
PREAI
Cardiac ryanodine receptor calcium release deficiency syndrome
2021-02-0367
OA
Common and rare susceptibility genetic variants predisposing to Brugada syndrome in Thailand
2020-12-0128
PREAI
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms ofCASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia
2020-09-0847
OAAI
Heart Rate Recovery After Exercise Is Associated With Arrhythmic Events in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
2020-03-0110
OAAI
Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest
2019-05-3082
OAAI
Pregnancy in Catecholaminergic Polymorphic Ventricular Tachycardia
2019-03-0119
PREAI
Linking the heart and the brain: Neurodevelopmental disorders in patients with catecholaminergic polymorphic ventricular tachycardia
2019-02-0127
OAAI